Recombinase activating gene 1 deficiency: genes and variants
Explore variant evidence for Recombinase activating gene 1 deficiency across 1 analyzed protein (RAG1). Linked ClinVar records include 8 pathogenic or likely pathogenic variants, 17 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Recombinase activating gene 1 deficiency
RAG1: V(D)J recombination-activating protein 1
It initiates V(D)J recombination by cutting antigen-receptor gene segments, creating the enormous receptor diversity required for adaptive immunity. Biallelic severe loss-of-function variants cause severe combined immunodeficiency, while hypomorphic alleles can cause Omenn syndrome or combined immunodeficiency with autoimmunity.
8 ClinVar pathogenic / likely pathogenic and 17 uncertain variants in RAG1 have source records linked to Recombinase activating gene 1 deficiency. Association strength is not clinical gene validity.
Where Recombinase activating gene 1 deficiency variants cluster
- RAG1 NBD (positions 392–459): 5 of 8 ClinVar pathogenic / likely pathogenic variants, 9.6× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Recombinase activating gene 1 deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| RAG1 R394W | 394 | NBD | Pathogenic / likely pathogenic (★★★) |
| RAG1 R394Q | 394 | NBD | Pathogenic / likely pathogenic (★★★) |
| RAG1 R396H | 396 | NBD | Pathogenic / likely pathogenic (★★★) |
| RAG1 R716Q | 716 | Pathogenic / likely pathogenic (★★★) | |
| RAG1 R561C | 561 | Pathogenic / likely pathogenic (★★★) | |
| RAG1 R699W | 699 | Pathogenic / likely pathogenic (★★★) | |
| RAG1 R404Q | 404 | NBD | Pathogenic / likely pathogenic (★★★) |
| RAG1 A444V | 444 | NBD | Pathogenic / likely pathogenic (★★★) |
Which prediction tools work for Recombinase activating gene 1 deficiency
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 99 out of 100
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 97 out of 100
- CADD: 96 out of 100
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 85 out of 100
- PolyPhen-2: 81 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 72 out of 100
- SpliceAI: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 48 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive also has ClinVar records linked to RAG1 variants; they fall mostly in different places as the Recombinase activating gene 1 deficiency variants (52 pathogenic / likely pathogenic).
- Combined immunodeficiency with skin granulomas also has ClinVar records linked to RAG1 variants; they fall mostly in different places as the Recombinase activating gene 1 deficiency variants (49 pathogenic / likely pathogenic).
- Combined immunodeficiency due to partial RAG1 deficiency also has ClinVar records linked to RAG1 variants; they fall mostly in different places as the Recombinase activating gene 1 deficiency variants (13 pathogenic / likely pathogenic).
- Histiocytic medullary reticulosis also has ClinVar records linked to RAG1 variants; they fall mostly in different places as the Recombinase activating gene 1 deficiency variants (11 pathogenic / likely pathogenic).
- Severe combined immunodeficiency also has ClinVar records linked to RAG1 variants; they fall mostly in different places as the Recombinase activating gene 1 deficiency variants (8 pathogenic / likely pathogenic).
Diseases related to Recombinase activating gene 1 deficiency
- Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive, also linked to RAG1
- Combined immunodeficiency with skin granulomas, also linked to RAG1
- Severe combined immunodeficiency, also linked to RAG1
- Histiocytic medullary reticulosis, also linked to RAG1
- Inherited Immunodeficiency Diseases, also linked to RAG1
- Combined immunodeficiency due to partial RAG1 deficiency, also linked to RAG1
Frequently asked questions
Which genes have records linked to Recombinase activating gene 1 deficiency?
This view contains 1 analyzed proteins: RAG1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 8 pathogenic or likely pathogenic variants, 17 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 41 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center